Tripp Levy PLLC, a leading national securities law firm, announces an investigation into the proposed acquisition of Immucor, Inc. (NASDAQ: BLUD) by TPG Capital for $27 per share in cash. The investigation concerns, among other things, whether the consideration to be paid to Immucor shareholders is unfair, inadequate, and substantially below the fair or inherent value of Immucor. Indeed, analysts have projected that Blackboard’s true going forward value is at least $28 per share. The investigation further concerns whether the board of directors of Immucor may have breached their fiduciary duties by not acting in Immucor shareholders' best interests in connection with the sale process of Immucor. If you own Immucor common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact
Tripp Levy PLLC is a national law firm that specializes in mergers & acquisitions, takeover litigation, shareholder rights, and corporate governance matters in state and federal courts throughout the United States. Attorney advertising. Prior results do not guarantee a similar outcome.
Shares of Immucor (Nasdaq:BLUD) have taken a tremendous swing upward. The stock is trading at $26.96 as of 9:31 a.m. ET, 30.1% above Friday's closing price of $20.73. Volume is at 1.8 million, 3.9 times the daily average of 464,400.